Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,081 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intelligence in DSM-IV combined type attention-deficit/hyperactivity disorder is not predicted by either dopamine receptor/transporter genes or other previously identified risk alleles for attention-deficit/hyperactivity disorder.
Sonuga-Barke EJ, Brookes KJ, Buitelaar J, Anney R, Bitsakou P, Baeyens D, Buschgens C, Chen W, Christiansen H, Eisenberg J, Kuntsi J, Manor I, Meliá A, Mulligan A, Rommelse N, Müller UC, Uebel H, Banaschewski T, Ebstein R, Franke B, Gill M, Miranda A, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Steinhausen HC, Thompson M, Taylor E, Asherson P, Faraone SV. Sonuga-Barke EJ, et al. Among authors: buitelaar j. Am J Med Genet B Neuropsychiatr Genet. 2008 Apr 5;147(3):316-9. doi: 10.1002/ajmg.b.30596. Am J Med Genet B Neuropsychiatr Genet. 2008. PMID: 18023044 Free article.
International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions.
Kutcher S, Aman M, Brooks SJ, Buitelaar J, van Daalen E, Fegert J, Findling RL, Fisman S, Greenhill LL, Huss M, Kusumakar V, Pine D, Taylor E, Tyano S. Kutcher S, et al. Among authors: buitelaar j. Eur Neuropsychopharmacol. 2004 Jan;14(1):11-28. doi: 10.1016/s0924-977x(03)00045-2. Eur Neuropsychopharmacol. 2004. PMID: 14659983 Review.
Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes.
Lowe N, Kirley A, Hawi Z, Sham P, Wickham H, Kratochvil CJ, Smith SD, Lee SY, Levy F, Kent L, Middle F, Rohde LA, Roman T, Tahir E, Yazgan Y, Asherson P, Mill J, Thapar A, Payton A, Todd RD, Stephens T, Ebstein RP, Manor I, Barr CL, Wigg KG, Sinke RJ, Buitelaar JK, Smalley SL, Nelson SF, Biederman J, Faraone SV, Gill M. Lowe N, et al. Among authors: buitelaar jk. Am J Hum Genet. 2004 Feb;74(2):348-56. doi: 10.1086/381561. Epub 2004 Jan 19. Am J Hum Genet. 2004. PMID: 14732906 Free PMC article.
European clinical guidelines for hyperkinetic disorder -- first upgrade.
Taylor E, Döpfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A. Taylor E, et al. Among authors: buitelaar j. Eur Child Adolesc Psychiatry. 2004;13 Suppl 1:I7-30. doi: 10.1007/s00787-004-1002-x. Eur Child Adolesc Psychiatry. 2004. PMID: 15322953 Free article.
1,081 results